Giant cell arteritis update

Seminars in Ophthalmology

Volumn 14, Issue 2, 1999, Pages 109-112

  Neff, Ann G ^a   Greifenstein, Elaine M ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; AZATHIOPRINE; BISPHOSPHONIC ACID DERIVATIVE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAPSONE; HORMONE; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; SALAZOSULFAPYRIDINE;

ARTERIOGRAPHY; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DIAGNOSTIC APPROACH ROUTE; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; GIANT CELL ARTERITIS; HORMONE SUBSTITUTION; HUMAN; INFECTION RISK; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; PATHOLOGIC FRACTURE; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

EID: 0033060236     PISSN: 08820538     EISSN: None     Source Type: Journal    
DOI: 10.3109/08820539909056070     Document Type: Review

References (23)

1. Lawrence RC, Helmick CG, Arnett FC, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum. 1998;41:778-799.
2. Hunder GG, Bloch DA, Michel BA, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990;33:1122-1128.
3. Hayreh SS, Podhajsky PA, Raman R, et al: Giant cell arteritis: Validity and reliability of various diagnostic criteria. Am J Ophthalmol. 1997;123:285-296.
4. Hayreh SS, Podhajsky PA, Zimmerman B. Ocular manifestations of giant cell arteritis. Am J Ophthalmol. 1998;125: 509-520.
5. Hayreh SS, Podhajsky PA, Zimmerman B. Occult giant cell arteritis: Ocular manifestations. Am J Ophthalmol. 1998; 125:521-526.
6. Reich KA, Giansiracusa DF, Strongwater SL. Neurologic manifestations of giant cell arteritis. Am J Med. 1990;89:67-72.
7. Caselli RJ, Hunder GG. Neurologic aspects of giant cell (temporal) arteritis. Rheum Dis Clin North Am. 1993;19:941-953.
8. Säve-Söderbergh J, Malmvall B, Andersson R, et al. Giant cell arteritis as a cause of death: Report of nine cases. JAMA. 1986;255:493-496.
9. Matteson EL, Gold KN, Bloch DA, et al. Long-term survival of patients with giant cell arteritis in the American College of Rheumatology giant cell arteritis classification criteria cohort. Am J Med. 1996;100:193-196.
10. Hauser WA, Ferguson RH, Holley KE, et al. Temporal arteritis in Rochester, Minnesota, 1951 to 1967. Mayo Clin Proc. 1971;46:597-602.
11. Huston KA, Hunder GG, Lie JT, et al. Temporal arteritis: A 25-year epidemiologic, clinical, and pathologic study. Ann Intern Med. 1978;88:162-167.
12. Kansu T, Corbett JJ, Savino P, et al. Giant cell arteritis with normal sedimentation rate. Arch Neurol. 1977;34:624-625.
13. Hayreh SS. Ophthalmic features of giant cell arteritis. Baillières Clin Rheumatol. 1991;5:431-459.
14. Galetta SL. Vasculitis. In: Miller NR, Newman NJ, eds. Walsh and Hoyt's Clinical Neuro-Ophthalmology. Baltimore, MD, Williams & Wilkins, 1998;3725-3886.
15. Ghanchi FD, Dutton GN. Current concepts in giant cell (temporal) arteritis. Surv Ophthalmol. 1997;42:99-123.
16. Scott KR, Tse DT. Temporal artery biopsy. In: Tse DT, Wright KW, eds. Color Atlas of Ophthalmic Surgery: Oculoplastic Surgery. Philadelphia, PA, J.B. Lipincott, 1992;463-472.
17. Achkar AA, Lie JT, Hunder GG, et al. How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis? Ann Intern Med. 1994;120: 987-992.
18. Kattah JC, Cupps T, Manz HJ, et al. Occipital artery biopsy: A diagnostic alternative in giant cell arteritis. Neurology. 1991;41:949-950.
19. Weems JJ. Diagnosis of giant cell arteritis by occipital artery biopsy. Ann J Med. 1992;93:231-232.
20. Albert DM, Ruchman MC, Keltner JL. Skip areas in temporal arteritis. Arch Ophthalmol. 1976;94:2072-2077.
21. Kachroo A, Tello C, Bais R, et al. Giant cell arteritis: Diagnosis and management. Bull Rheum Dis. 1996;45:2-5.
22. American College of Rheumatology Task Force on Osteoporosis Guidelines. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheum. 1996;39:1791-1801.
23. Hellmann DB. Immunopathogenesis, diagnosis, and treatment of giant cell arteritis, temporal arteritis, polymyalgia rheumatica, and Takayasu's arteritis. Curr Opin Rheumatol. 1993;5:25-32.